{"transactions":[{"id":671934,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":3583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.52,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":3583},"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671933,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":false,"shares":41927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are fully vested."}],"balance_after":2773,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":41927},"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671932,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":3161,"price":37.5396,"value":118662.6756,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $37.46 to $37.65. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671931,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"sale","planned":true,"acquired":false,"shares":42349,"price":37.0925,"value":1570830.2825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $36.46 to $37.45. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":3161,"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671930,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":3583,"price":2.52,"value":9029.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."}],"balance_after":45510,"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":671929,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-31T21:01:57.000Z","date":"2026-08-27","kind":"exercise","planned":true,"acquired":true,"shares":41927,"price":5.64,"value":236468.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transactions effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 28, 2026."}],"balance_after":41927,"source":{"system":"sec-edgar","filing":"0001193125-26-377001","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526377001/ownership.xml","form_type":"4"}},{"id":696289,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-05T20:30:34.000Z","date":"2026-08-03","kind":"other","planned":true,"acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option."}],"balance_after":3497,"derivative":{"exercise_price":7.7,"exercise_date":"2027-08-03","expiration_date":"2037-08-03","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001493152-26-036187","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000149315226036187/ownership.xml","form_type":"4"}},{"id":717663,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T20:15:06.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":32341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) July 1, 2027 or (ii) the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer."}],"balance_after":32341,"derivative":{"exercise_price":18.48,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":32341},"source":{"system":"sec-edgar","filing":"0001193125-26-294546","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526294546/ownership.xml","form_type":"4"}},{"id":734152,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-17T20:46:58.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 5, 2026 will become vested on the earlier of (i) June 5, 2027 or (ii) the business day prior to the 2027 annual meeting of stockholder."}],"balance_after":16377,"derivative":{"exercise_price":35.59,"exercise_date":"2027-06-02","expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":16377},"source":{"system":"sec-edgar","filing":"0001362520-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000136252026000001/primarydocument.xml","form_type":"4"}},{"id":741478,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:30:06.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":17901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":17901,"derivative":{"exercise_price":31.98,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":17901},"source":{"system":"sec-edgar","filing":"0001193125-26-267667","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000119312526267667/ownership.xml","form_type":"4"}},{"id":973292,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-11T22:00:19.000Z","date":"2025-12-09","kind":"grant","planned":true,"acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options."}],"balance_after":5927,"derivative":{"exercise_price":21.38,"exercise_date":"2026-12-09","expiration_date":"2035-12-09","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001493152-25-027271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000149315225027271/ownership.xml","form_type":"4"}},{"id":973291,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-11T22:00:19.000Z","date":"2025-12-09","kind":"grant","planned":true,"acquired":true,"shares":2400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9, 2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options."}],"balance_after":3527,"derivative":{"exercise_price":21.38,"exercise_date":"2026-12-09","expiration_date":"2035-12-09","underlying":"Common Stock","underlying_shares":2400},"source":{"system":"sec-edgar","filing":"0001493152-25-027271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000149315225027271/ownership.xml","form_type":"4"}},{"id":1094783,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T20:45:26.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) July 1, 2026 or (ii) the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board of Directors of the Issuer."}],"balance_after":21000,"derivative":{"exercise_price":14.47,"expiration_date":"2035-07-01","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000950170-25-093107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000095017025093107/ownership.xml","form_type":"4"}},{"id":1106348,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T23:36:38.000Z","date":"2025-06-16","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 16, 2025 will become vested on the earlier of (i) June 16, 2026 or (ii) the business day prior to the 2026 annual meeting of stockholders."}],"balance_after":30000,"derivative":{"exercise_price":14.68,"exercise_date":"2026-06-16","expiration_date":"2035-06-16","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001562180-25-004958","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218025004958/primarydocument.xml","form_type":"4"}},{"id":1121143,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T20:17:57.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2026 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":5.64,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-25-082348","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000095017025082348/ownership.xml","form_type":"4"}},{"id":1454087,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-16T20:31:16.000Z","date":"2023-07-15","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on June 4, 2025, and in the event that the director does not serve until June 30, 2025, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on July 31, 2024.  The options were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options.  The required certification was made on July 15, 2024."}],"balance_after":57180,"derivative":{"exercise_price":1.83,"exercise_date":"2025-06-04","expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001654954-24-008998","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495424008998/section16.xml","form_type":"4"}},{"id":1454086,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-16T20:31:16.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 4, 2025. The restricted share units were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options.  The required certification was made on July 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 4, 2025. The restricted share units were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options.  The required certification was made on July 15, 2024."}],"balance_after":41580,"source":{"system":"sec-edgar","filing":"0001654954-24-008998","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495424008998/section16.xml","form_type":"4"}},{"id":1467116,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-28T20:05:08.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) June 26, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service on the Board."}],"balance_after":21000,"derivative":{"exercise_price":12.31,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0000950170-24-079038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000095017024079038/ownership.xml","form_type":"4"}},{"id":1480434,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-13T23:06:46.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":44700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2025 Annual Meeting of Stockholders."}],"balance_after":44700,"derivative":{"exercise_price":8.92,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":44700},"source":{"system":"sec-edgar","filing":"0000950170-24-073226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000095017024073226/ownership.xml","form_type":"4"}},{"id":1482129,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-12T23:26:21.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":20594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the Stock Options granted on June 10, 2024 will become vested on the earlier of (i) June 10, 2025 or (ii) the business day prior to the 2025 annual meeting of stockholders."}],"balance_after":20594,"derivative":{"exercise_price":17.13,"exercise_date":"2025-06-10","expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":20594},"source":{"system":"sec-edgar","filing":"0001562180-24-005020","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024005020/primarydocument.xml","form_type":"4"}},{"id":1524800,"issuer":{"id":3965,"kind":"organization","name":"Edgewise Therapeutics, Inc."},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2024-05-07T23:52:00.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":34311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest each month beginning on June 6, 2024, subject to the Reporting Person continuing as a service provider through each vest date."}],"balance_after":34311,"derivative":{"exercise_price":20.34,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":34311},"source":{"system":"sec-edgar","filing":"0001562180-24-003899","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1710072/000156218024003899/primarydocument.xml","form_type":"4"}},{"id":1847096,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-22T21:00:29.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests on June 30, 2024, and in the event that the director does not serve until June 30, 2024, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on July 31, 2023."}],"balance_after":16000,"derivative":{"exercise_price":2.19,"exercise_date":"2024-06-30","expiration_date":"2033-06-20","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001654954-23-008307","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495423008307/section16.xml","form_type":"4"}},{"id":1847095,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-22T21:00:29.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 20, 2024."}],"balance_after":45093,"source":{"system":"sec-edgar","filing":"0001654954-23-008307","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495423008307/section16.xml","form_type":"4"}},{"id":1851898,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T23:51:24.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) June 14, 2024 or (ii) the Issuer's 2024 annual meeting of stockholders, subject to Reporting Person's continued service on the Board."}],"balance_after":20000,"derivative":{"exercise_price":27.67,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-23-028721","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000095017023028721/ownership.xml","form_type":"4"}},{"id":1862081,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:58:20.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":36700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2024 Annual Meeting of Stockholders."}],"balance_after":36700,"derivative":{"exercise_price":11.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":36700},"source":{"system":"sec-edgar","filing":"0000899243-23-014905","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000089924323014905/doc4.xml","form_type":"4"}},{"id":2064187,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2023-01-05T16:03:02.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the earlier of December 1, 2023 or the closing of a Sale Event (as defined in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan), subject to the reporting person's continuous service to the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the earlier of December 1, 2023 or the closing of a Sale Event (as defined in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan), subject to the reporting person's continuous service to the Issuer."}],"balance_after":36000,"derivative":{"underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001437749-23-000482","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774923000482/rdgdoc.xml","form_type":"4"}},{"id":2222394,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-24T23:31:59.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":128000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2022."}],"balance_after":128000,"derivative":{"exercise_price":0.29,"exercise_date":"2022-07-31","expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0001654954-22-008783","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495422008783/section16.xml","form_type":"4"}},{"id":2222393,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-24T23:31:59.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":73000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2023."}],"balance_after":903667,"source":{"system":"sec-edgar","filing":"0001654954-22-008783","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495422008783/section16.xml","form_type":"4"}},{"id":2235735,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-10T11:30:10.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) June 8, 2023 or (ii) the Issuer's 2023 annual meeting of stockholders, subject to Reporting Person's continued service on the Board."}],"balance_after":12500,"derivative":{"exercise_price":12.31,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-22-021801","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000089924322021801/doc4.xml","form_type":"4"}},{"id":2237558,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T21:10:20.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":30700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This annual stock option award was made on the date of the 2022 Annual Meeting of Stockholders pursuant to the company's Non-Employee Director Compensation Program and shall vest in full upon the earlier of the first anniversary of the date of grant or the date of the 2023 Annual Meeting of Stockholders."}],"balance_after":30700,"derivative":{"exercise_price":4.59,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":30700},"source":{"system":"sec-edgar","filing":"0000899243-22-021646","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000089924322021646/doc4.xml","form_type":"4"}},{"id":2442167,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Purchase)","published_at":"2022-01-06T16:03:37.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan, as amended (the \"2013 Plan\") and received 22,000 non-qualified stock options on January 4, 2022 (the \"Grant Date\"). The non-qualified stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date."}],"balance_after":22000,"derivative":{"exercise_price":1.26,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001437749-22-000547","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774922000547/rdgdoc.xml","form_type":"4"}},{"id":2646003,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-07-02T15:20:38.000Z","date":"2021-07-01","kind":"purchase","acquired":true,"shares":33000,"price":0.62,"value":20460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Amended to reflect open market purchases of non-derivative security."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average of price paid per share on order, with prices per share ranging from $0.6149 to $0.6217. The reporting person hereby undertakes upon request to provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":698666,"source":{"system":"sec-edgar","filing":"0001654954-21-007565","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495421007565/section16.xml","form_type":"4/A","original_submission_date":"2021-07-01"}},{"id":2648606,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-07-01T19:37:31.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":33000,"price":0.62,"value":20460.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average of price paid per share on order, with prices per share ranging from $0.6149 to $0.6217. The reporting person hereby undertakes upon request to provide to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":698666,"source":{"system":"sec-edgar","filing":"0001654954-21-007511","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495421007511/section16.xml","form_type":"4"}},{"id":2655262,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Purchase)","published_at":"2021-06-25T16:06:25.000Z","date":"2021-06-23","kind":"grant","acquired":true,"shares":51700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the \"Plan\") and received 51,700 non-qualified stock options on June 23, 2021 (the \"Grant Date\"). The non-qualified stock options shall vest and become exercisable in 48 equal monthly installments from the Grant Date."}],"balance_after":51700,"derivative":{"exercise_price":2.73,"expiration_date":"2031-06-22","underlying":"Common Stock","underlying_shares":51700},"source":{"system":"sec-edgar","filing":"0001437749-21-015657","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774921015657/rdgdoc.xml","form_type":"4"}},{"id":2656466,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-06-24T21:01:25.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":128000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2021."}],"balance_after":128000,"derivative":{"exercise_price":0.55,"exercise_date":"2021-07-31","expiration_date":"2031-06-22","underlying":"Common stock","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0001654954-21-007256","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495421007256/section16.xml","form_type":"4"}},{"id":2656465,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2021-06-24T21:01:25.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2022."}],"balance_after":665666,"source":{"system":"sec-edgar","filing":"0001654954-21-007256","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495421007256/section16.xml","form_type":"4"}},{"id":2666039,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T22:27:17.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full upon the earlier to occur of (i) June 3, 2022 or (ii) the Issuer's 2022 annual meeting of stockholders, subject to Reporting Person's continued service on the Board."}],"balance_after":12500,"derivative":{"exercise_price":16.6,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-024221","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000089924321024221/doc4.xml","form_type":"4"}},{"id":2789044,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-15T22:54:53.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in equal monthly installments over a three year period."}],"balance_after":60000,"derivative":{"exercise_price":8.45,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-21-011688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000089924321011688/doc4.xml","form_type":"4"}},{"id":2874336,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-02-08T22:38:06.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vest monthly over a three year period, subject to Reporting Person's continued service on the Board."}],"balance_after":25000,"derivative":{"exercise_price":20.5,"expiration_date":"2031-02-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-21-005204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000089924321005204/doc4.xml","form_type":"4"}},{"id":2899832,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2021-01-22T19:17:00.000Z","date":"2021-01-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents the contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 25,000 RSUs on January 20, 2021 (the \"Grant Date\"). The RSUs vest in full on the second anniversary of the Grant Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 25,000 RSUs on January 20, 2021 (the \"Grant Date\"). The RSUs vest in full on the second anniversary of the Grant Date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-21-001111","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774921001111/rdgdoc.xml","form_type":"4"}},{"id":3025439,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Purchase)","published_at":"2020-09-22T11:04:40.000Z","date":"2020-09-21","kind":"grant","acquired":true,"shares":165000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the \"Plan\") and received 165,000 non-qualified stock options on September 21, 2020 (the \"Grant Date\"). The non-qualified stock options shall vest in full on the first anniversary of the Grant Date."}],"balance_after":165000,"derivative":{"exercise_price":0.5397,"expiration_date":"2030-09-20","underlying":"Common Stock","underlying_shares":165000},"source":{"system":"sec-edgar","filing":"0001437749-20-019987","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774920019987/rdgdoc.xml","form_type":"4"}},{"id":3105940,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T21:01:25.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":127000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020."}],"balance_after":127000,"derivative":{"exercise_price":0.58,"exercise_date":"2020-07-30","expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":127000},"source":{"system":"sec-edgar","filing":"0001654954-20-006787","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495420006787/section16.xml","form_type":"4"}},{"id":3105939,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-18T21:01:25.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":73000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021."}],"balance_after":445583,"source":{"system":"sec-edgar","filing":"0001654954-20-006787","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495420006787/section16.xml","form_type":"4"}},{"id":3113226,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-11T20:24:59.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":14331,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) June 9, 2021, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":14331,"derivative":{"exercise_price":0.63,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":14331},"source":{"system":"sec-edgar","filing":"0001209191-20-035928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919120035928/doc4.xml","form_type":"4"}},{"id":3136983,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-22T21:18:29.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":24000,"derivative":{"exercise_price":0.6261,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-20-031835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919120031835/doc4.xml","form_type":"4"}},{"id":3358068,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2019-11-27T19:30:41.000Z","date":"2019-11-26","kind":"grant","acquired":true,"shares":330000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in 48 equal monthly installments after November 26, 2019, subject to the Reporting Person's continuous service to the Issuer through each such date."}],"balance_after":330000,"derivative":{"exercise_price":0.869,"expiration_date":"2029-11-25","underlying":"Common Stock","underlying_shares":330000},"source":{"system":"sec-edgar","filing":"0001437749-19-023674","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774919023674/rdgdoc.xml","form_type":"4"}},{"id":3454264,"issuer":{"id":3793,"kind":"organization","name":"Cogent Biosciences, Inc.","symbol":"COGT"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-29T20:06:49.000Z","date":"2019-07-26","kind":"grant","acquired":true,"shares":28661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option shall vest in 36 equal monthly installments; subject to continued service to the Issuer."}],"balance_after":28661,"derivative":{"exercise_price":2.05,"expiration_date":"2029-07-26","underlying":"Common Stock","underlying_shares":28661},"source":{"system":"sec-edgar","filing":"0001209191-19-043470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919119043470/doc4.xml","form_type":"4"}},{"id":3478338,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-26T20:38:25.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2019."}],"balance_after":52000,"derivative":{"exercise_price":1.34,"exercise_date":"2019-07-31","expiration_date":"2029-06-24","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001654954-19-007690","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495419007690/section16.xml","form_type":"4"}},{"id":3478337,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-26T20:38:25.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock.  The restricted share units vest on June 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock.  The restricted share units vest on June 24, 2020."}],"balance_after":335333,"source":{"system":"sec-edgar","filing":"0001654954-19-007690","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495419007690/section16.xml","form_type":"4"}},{"id":3481195,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-21T21:17:19.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":2.36,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-038573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919119038573/doc4.xml","form_type":"4"}},{"id":3506763,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Purchase)","published_at":"2019-05-31T16:31:14.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the \"Plan\") and received 35,000 non-qualified stock options on May 29, 2019 (the \"Grant Date\"). The non-qualified stock options shall vest in full on the first anniversary of the Grant Date."}],"balance_after":35000,"derivative":{"exercise_price":0.58,"expiration_date":"2029-05-28","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001437749-19-011165","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774919011165/rdgdoc.xml","form_type":"4"}},{"id":3755406,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-21T17:03:59.000Z","date":"2018-11-20","kind":"purchase","acquired":true,"shares":100,"price":0.6878,"value":68.78,"ownership":{"direct":true},"balance_after":288999,"source":{"system":"sec-edgar","filing":"0001654954-18-013089","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495418013089/section16.xml","form_type":"4"}},{"id":3755405,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-21T17:03:59.000Z","date":"2018-11-20","kind":"purchase","acquired":true,"shares":2100,"price":0.6855,"value":1439.55,"ownership":{"direct":true},"balance_after":288899,"source":{"system":"sec-edgar","filing":"0001654954-18-013089","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495418013089/section16.xml","form_type":"4"}},{"id":3755404,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-21T17:03:59.000Z","date":"2018-11-20","kind":"purchase","acquired":true,"shares":100,"price":0.6854,"value":68.54,"ownership":{"direct":true},"balance_after":286799,"source":{"system":"sec-edgar","filing":"0001654954-18-013089","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495418013089/section16.xml","form_type":"4"}},{"id":3755403,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-21T17:03:59.000Z","date":"2018-11-20","kind":"purchase","acquired":true,"shares":100,"price":0.6853,"value":68.53,"ownership":{"direct":true},"balance_after":286699,"source":{"system":"sec-edgar","filing":"0001654954-18-013089","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495418013089/section16.xml","form_type":"4"}},{"id":3755402,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-21T17:03:59.000Z","date":"2018-11-20","kind":"purchase","acquired":true,"shares":9600,"price":0.6852,"value":6577.92,"ownership":{"direct":true},"balance_after":286599,"source":{"system":"sec-edgar","filing":"0001654954-18-013089","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495418013089/section16.xml","form_type":"4"}},{"id":3783684,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Purchase)","published_at":"2018-10-25T12:48:33.000Z","date":"2018-10-23","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the \"Plan\") and received 17,500 non-qualified stock options on October 23, 2018 (the \"Grant Date\"). The non-qualified stock options shall vest in full on May 22, 2019."}],"balance_after":17500,"derivative":{"exercise_price":3.47,"expiration_date":"2028-10-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001437749-18-018777","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774918018777/rdgdoc.xml","form_type":"4"}},{"id":3881317,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-28T20:46:57.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":6.46,"expiration_date":"2028-06-26","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-18-039891","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919118039891/doc4.xml","form_type":"4"}},{"id":3881716,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-28T20:45:30.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2018."}],"balance_after":28000,"derivative":{"exercise_price":1,"exercise_date":"2018-07-31","expiration_date":"2028-06-26","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001654954-18-007111","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495418007111/section16.xml","form_type":"4"}},{"id":3881715,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-28T20:45:30.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock.  The restricted share units vest on June 26, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock.  The restricted share units vest on June 26, 2019."}],"balance_after":273333,"source":{"system":"sec-edgar","filing":"0001654954-18-007111","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495418007111/section16.xml","form_type":"4"}},{"id":3921154,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Purchase)","published_at":"2018-05-23T16:20:10.000Z","date":"2018-05-22","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the \"Plan\") and received 17,500 non-qualified stock options on May 22, 2018 (the \"Grant Date\"). The non-qualified stock options shall vest in full on the first anniversary of the Grant Date."}],"balance_after":17500,"derivative":{"exercise_price":1.75,"expiration_date":"2028-05-21","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001437749-18-010594","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774918010594/rdgdoc.xml","form_type":"4"}},{"id":4133886,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-12-13T21:27:46.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest at the rate of one-third per year, starting on December 12, 2018."}],"balance_after":30000,"derivative":{"exercise_price":0.85,"exercise_date":"2018-12-12","expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001654954-17-011597","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495417011597/section16.xml","form_type":"4"}},{"id":4133885,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T21:27:46.000Z","date":"2017-12-12","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock.  The restricted share units vest at the rate of one-third per year starting on December 12, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock.  The restricted share units vest at the rate of one-third per year starting on December 12, 2018."}],"balance_after":196500,"source":{"system":"sec-edgar","filing":"0001654954-17-011597","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495417011597/section16.xml","form_type":"4"}},{"id":4170078,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:10:23.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":17000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These options, which vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board, were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options, which vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board, were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-059631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919117059631/doc4.xml","form_type":"4"}},{"id":4170077,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:10:23.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":32069,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were assumed by Ultragenyx and converted in accordance with the exchange ratio as set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":7.08,"expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":32069},"source":{"system":"sec-edgar","filing":"0001209191-17-059631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919117059631/doc4.xml","form_type":"4"}},{"id":4170076,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T22:10:23.000Z","date":"2017-11-07","kind":"disposition_to_issuer","acquired":false,"shares":44474,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This stock option, which vests in equal monthly installments over 48 months beginning June 3, 2015, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option, which vests in equal monthly installments over 48 months beginning June 3, 2015, was assumed by Ultragenyx Pharmaceutical Inc. (\"Ultragenyx\"), and converted in accordance with the exchange ratio as set forth in the Agreement and Plan of Merger (the \"Merger Agreement\"), dated October 2, 2017, between the Issuer, Ultragenyx and Mystic River Merger Sub Inc., a direct, wholly-owned subsidiary of Ultragenyx."}],"balance_after":0,"derivative":{"exercise_price":4.85,"expiration_date":"2025-08-11","underlying":"Common Stock","underlying_shares":44474},"source":{"system":"sec-edgar","filing":"0001209191-17-059631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919117059631/doc4.xml","form_type":"4"}},{"id":4214028,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Purchase)","published_at":"2017-09-08T20:36:43.000Z","date":"2017-09-06","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the \"Plan\") and received 17,500 non-qualified stock options on September 6, 2017 (the \"Grant Date\"). The non-qualified stock options shall vest in full on the first anniversary of the Grant Date."}],"balance_after":17500,"derivative":{"exercise_price":5.58,"expiration_date":"2027-09-05","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001437749-17-015822","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774917015822/rdgdoc.xml","form_type":"4"}},{"id":4274890,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T20:20:05.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2017."}],"balance_after":54000,"derivative":{"exercise_price":0.37,"exercise_date":"2017-07-31","expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001654954-17-005815","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495417005815/section16.xml","form_type":"4"}},{"id":4274889,"issuer":{"id":7649,"kind":"organization","name":"PALATIN TECHNOLOGIES INC"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-22T20:20:05.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock.  The restricted share units vest on June 20, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock.  The restricted share units vest on June 20, 2018."}],"balance_after":183500,"source":{"system":"sec-edgar","filing":"0001654954-17-005815","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/911216/000165495417005815/section16.xml","form_type":"4"}},{"id":4302846,"issuer":{"id":172012,"kind":"organization","name":"Dimension Therapeutics, Inc.","symbol":"DMTX"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T20:28:08.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest in full on the earlier of May 25, 2018 or the Issuer's next annual meeting of stockholders, subject to the director's continued service on the Board."}],"balance_after":17000,"derivative":{"exercise_price":1.15,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001209191-17-035828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1362520/000120919117035828/doc4.xml","form_type":"4"}},{"id":4511598,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Purchase)","published_at":"2016-12-28T21:00:33.000Z","date":"2016-12-23","kind":"grant","acquired":true,"shares":25160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan and received 25,160 non-qualified stock options on December 23, 2016 (the \"Grant Date\"). The non-qualified stock options will vest in equal monthly increments over 48 months following the Grant Date."}],"balance_after":25160,"derivative":{"exercise_price":5.22,"expiration_date":"2026-12-22","underlying":"Common Stock","underlying_shares":25160},"source":{"system":"sec-edgar","filing":"0001437749-16-043881","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774916043881/rdgdoc.xml","form_type":"4"}},{"id":4559094,"issuer":{"id":11899,"kind":"organization","name":"VIVEVE MEDICAL, INC.","symbol":"VIVE"},"owners":[{"id":18365,"kind":"person","name":"Morris Arlene","position":1,"cik":"0001362520","reported_name":"Morris Arlene","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-11-14T16:03:14.000Z","date":"2016-11-09","kind":"grant","acquired":true,"shares":1442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the \"Plan\") and received a restricted stock award of 1,442 shares of common stock on November 9, 2016 (the \"Grant Date\").  The restricted stock award vested in the full on the Grant Date."}],"balance_after":2482,"source":{"system":"sec-edgar","filing":"0001437749-16-042056","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879682/000143774916042056/rdgdoc.xml","form_type":"4"}}]}